Skip to content

Innovative team for clinical efficacy evaluation and mechanism research of traditional Chinese medicine in treating COVID-19 -- clinical efficacy evaluation of traditional Chinese medicine injection in treating COVID-19

Innovative team for clinical efficacy evaluation and mechanism research of traditional Chinese medicine in treating COVID-19 -- clinical efficacy evaluation of traditional Chinese medicine injection in treating COVID-19

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068907
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

tanreqing group:None
redu'ning group:None
xuebijing group:None
xiyanping group:None
Western medicine group:None

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for common, severe and critical types of the Novel Coronavirus Pneumonia Diagnosis and Treatment Protocol (Trial ninth Edition). 2. Aged at least 18 years. 3. Xuebijing, Xiyanping, Tanreqing, Reduning injection and pure Western medicine were used for treatment for 3 days or more. 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Mentally ill people, or others who are unable or unwilling to cooperate. 2. Participate in other tests within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Time for COVID-19 to turn negative;

Secondary

MeasureTime frame
Time of disappearance of single symptoms such as fever and cough;Time of complete antipyretic;Cough relief time;Number and duration of inpatients in ICU;28-day case fatality rate;Number of cases with non COVID-19 microbial infection and name of pathogenic microorganism;Imaging improvement;Number of shock cases and shock time;Mean time of severe illness;Time and dose of hormone use;Length of hospital stay;

Countries

China

Contacts

Public ContactLiu Qingquan

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

liuqingquan2003@126.com+86 132 6039 7833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026